Orasone Interactions
There are 627 drugs known to interact with Orasone (prednisone), along with 22 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 79 are major, 505 are moderate, and 43 are minor.
- View all 627 medications that may interact with Orasone
- View Orasone alcohol/food interactions (2)
- View Orasone disease interactions (22)
Most frequently checked interactions
View interaction reports for Orasone (prednisone) and the medicines listed below.
- acetaminophen
- acetaminophen
- amlodipine
- amlodipine
- Aspercreme Maximum Strength Lidocaine Patch (lidocaine topical)
- Aspercreme Maximum Strength Lidocaine Patch (lidocaine topical)
- atenolol
- atenolol
- atorvastatin
- atorvastatin
- Azithromycin Dose Pack (azithromycin)
- Azithromycin Dose Pack (azithromycin)
- cefdinir
- cefdinir
- clopidogrel
- clopidogrel
- Combivent Respimat (albuterol / ipratropium)
- Combivent Respimat (albuterol / ipratropium)
- docusate
- docusate
- Flomax (tamsulosin)
- Flomax (tamsulosin)
- fludrocortisone
- fludrocortisone
- fluticasone / salmeterol
- fluticasone / salmeterol
- hydrochlorothiazide
- hydrochlorothiazide
- losartan
- losartan
Orasone alcohol/food interactions
There are 2 alcohol/food interactions with Orasone (prednisone).
Orasone disease interactions
There are 22 disease interactions with Orasone (prednisone) which include:
- infections
- (+) tuberculin test
- cirrhosis
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hyperlipidemia
- hypothyroidism
- liver disease
- MI
- myasthenia gravis
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- scleroderma
- strongyloidiasis
- thromboembolism
Report options
More about Orasone (prednisone)
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: glucocorticoids
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Nplate
Nplate is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Benlysta
Benlysta infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ...
Saphnelo
Saphnelo is used for moderate to severe SLE (lupus) for adults who are also receiving other lupus ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
